| Title |
Role |
Status |
| Activated Protein C in Acute Stroke Trial |
Lead Sponsor |
 |
| Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke |
Lead Sponsor |
 |
| Stroke and MI in Users of Estrogen/Progestogen |
Lead Sponsor |
 |
| Postmenopausal Progestins, MI and Stroke |
Lead Sponsor |
 |
| Stroke Risk in the NAS-NRC Twin Registry |
Lead Sponsor |
 |
| Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke |
Lead Sponsor |
 |
| Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II |
Lead Sponsor |
 |
| Honolulu Heart Program-Study of Stroke and Dementia |
Lead Sponsor |
 |
| Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHS |
Lead Sponsor |
 |
| Evaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study) |
Lead Sponsor |
 |
| Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial |
Collaborator |
 |
| Systolic Blood Pressure Intervention Trial |
Lead Sponsor |
 |
| Cardiovascular Health Study (CHS) |
Lead Sponsor |
 |
| Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs |
Collaborator |
 |
| Look AHEAD: Action for Health in Diabetes |
Collaborator |
 |
| Dietary Patterns and Risk of Cardiovascular Disease |
Lead Sponsor |
 |
| Multi-Ethnic Study of Atherosclerosis (MESA) |
Lead Sponsor |
 |
| Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease |
Lead Sponsor |
 |
| Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center |
Lead Sponsor |
 |
| Analyzing How Genetics May Affect Response to High Blood Pressure Medications |
Lead Sponsor |
 |
| Evaluating the Relationship Between Fatty Acids and Heart Disease |
Lead Sponsor |
 |
| Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea |
Collaborator |
 |
| Prospective Study of Diet and Cardiovascular Disease |
Lead Sponsor |
 |
| Antihypertensive Drug/Gene Interactions and CV Events |
Lead Sponsor |
 |
| Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center |
Lead Sponsor |
 |
| Job Strain, Ambulatory Blood Pressure and Hypertension |
Lead Sponsor |
 |
| Pharmacogenetics and Cardiovascular Events |
Lead Sponsor |
 |
| Cardiovascular Health Study (CHS) Events Follow-up Study |
Lead Sponsor |
 |
| Hormone Replacement Therapy and Prothrombotic Variants |
Lead Sponsor |
 |
| Atherosclerosis, Plaque and CVD in Communities |
Lead Sponsor |
 |
| Honolulu Heart Program |
Lead Sponsor |
 |
| Homocyst(e)Ine, Vitamin Status, and CVD Risk |
Lead Sponsor |
 |
| Atrial Fibrillation Incidence, Risk Factors and Genetics |
Lead Sponsor |
 |
| Nurses' Health Study |
Lead Sponsor |
 |
| Sleep Heart Health Study (SHHS) |
Lead Sponsor |
 |
| Coronary Artery Calcium, Exercise Tests, and CHD Outcome |
Lead Sponsor |
 |
| Mode Selection Trial in Sinus Node Dysfunction (MOST) |
Lead Sponsor |
 |
| Inflammation, Infection, and Future Cardiovascular Risk |
Lead Sponsor |
 |
| Health Professionals Follow-up Study |
Lead Sponsor |
 |
| Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) |
Lead Sponsor |
 |
| Carotid Atherosclerosis Follow-Up Study |
Lead Sponsor |
 |
| Identifying Genes That May Increase the Risk for Heart Disease in African Americans |
Lead Sponsor |
 |
| Paraoxonase and LDL Oxidation in Carotid Artery Disease |
Collaborator |
 |
| Flavonoids and Cardiovascular Disease |
Lead Sponsor |
 |
| Mortality Follow-Up and Analyses of Men in the MRFIT |
Lead Sponsor |
 |
| Cardiac and Renal Disease Study (CARDS) |
Lead Sponsor |
 |
| Prediction of Quality of Life in Cardiovascular Disease |
Lead Sponsor |
 |
| The ARIC MRI Study |
Lead Sponsor |
 |
| Framingham Heart Study |
Lead Sponsor |
 |
| Evans County Studies |
Lead Sponsor |
 |
| Epidemiology of Insulin Growth Factor (IGF) and Cardiovascular Events |
Lead Sponsor |
 |
| Low Cholesterol and Mortality in Blacks and Women |
Lead Sponsor |
 |
| Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago |
Lead Sponsor |
 |
| Stanford Five-City Multifactor Risk Reduction Study |
Lead Sponsor |
 |
| Community Structure and Cardiovascular Mortality Trends |
Lead Sponsor |
 |
| Minnesota Heart Survey - Risk Factor Survey |
Lead Sponsor |
 |
| Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC |
Lead Sponsor |
 |
| Infection and Cardiovascular Disease |
Lead Sponsor |
 |
| Minnesota Heart Health Program |
Lead Sponsor |
 |
| Pawtucket Heart Health Program |
Lead Sponsor |
 |
| Mortality Surveillance of MRFIT Screenees |
Lead Sponsor |
 |
| Predictors of Cardiovascular Disease in the Elderly |
Lead Sponsor |
 |
| Lifestyle and Chronic Disease in College Alumni (Harvard Alumni Health Study) |
Lead Sponsor |
 |
| Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective |
Lead Sponsor |
 |
| Western Collaborative Group Study (WCGS): 25-Year Follow-Up of Cardiovascular Disease Morbidity and Mortality |
Lead Sponsor |
 |
| Salt Sensitivity, Cardiovascular and Metabolic Disease |
Lead Sponsor |
 |
| Observational Aspirin Use and CVD in the Physicians' Health Study |
Lead Sponsor |
 |
| Epidemiology of Vascular Inflammation & Atherosclerosis |
Lead Sponsor |
 |
| Plaque Inflammation and Dysfunctional HDL Cholesterol in Participants Receiving Niacin and Statins in the AIM-HIGH Study (The HDL Proteomics Study) |
Lead Sponsor |
 |
| Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery |
Lead Sponsor |
 |
| Stroke Prevention in Sickle Cell Anemia (STOP 1) |
Lead Sponsor |
 |
| Recurrent Carotid Stenosis |
Lead Sponsor |
 |
| Stroke Prevention in Sickle Cell Anemia (STOP 2) |
Lead Sponsor |
 |
| Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) |
Lead Sponsor |
 |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) |
Lead Sponsor |
 |
| Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) |
Lead Sponsor |
 |
| Niacin Plus Statin to Prevent Vascular Events |
Lead Sponsor |
 |
| Predictors of Recurrent Stroke in the PROGRESS Study |
Lead Sponsor |
 |
| Stroke Belt Initiative |
Lead Sponsor |
 |
| Pooled Analysis of NHANES I/II--Race, Gender, and CHD |
Lead Sponsor |
 |
| Clarification of Optimal Anticoagulation Through Genetics |
Lead Sponsor |
 |
| Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis |
Collaborator |
 |
| Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) |
Lead Sponsor |
 |
| Effectiveness of a Barbershop-Based Program to Improve High Blood Pressure Control and Awareness in Black Men |
Lead Sponsor |
 |
| Vitamin D and Omega-3 Trial (VITAL) |
Collaborator |
 |
| Sleep Apnea in Transient Ischemic Attack(TIA)/Stroke:Reducing Cardiovascular Risk With Positive Airway Pressure(Sleep Tight) |
Collaborator |
 |
| Vitamin D, Insulin Resistance, and Cardiovascular Disease |
Collaborator |
 |
| Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery |
Collaborator |
 |
| Cardiovascular Inflammation Reduction Trial |
Collaborator |
 |